CA2544460A1 - Controlled-release biocompatible ocular drug delivery implant devices and methods - Google Patents
Controlled-release biocompatible ocular drug delivery implant devices and methods Download PDFInfo
- Publication number
- CA2544460A1 CA2544460A1 CA002544460A CA2544460A CA2544460A1 CA 2544460 A1 CA2544460 A1 CA 2544460A1 CA 002544460 A CA002544460 A CA 002544460A CA 2544460 A CA2544460 A CA 2544460A CA 2544460 A1 CA2544460 A1 CA 2544460A1
- Authority
- CA
- Canada
- Prior art keywords
- methods
- devices
- controlled
- release
- drug delivery
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000013270 controlled release Methods 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 238000012377 drug delivery Methods 0.000 title 1
- 239000007943 implant Substances 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 5
- 229940079593 drug Drugs 0.000 abstract 5
- 230000007613 environmental effect Effects 0.000 abstract 1
- 239000012530 fluid Substances 0.000 abstract 1
Landscapes
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Controlled release devices are disclosed which are biocompatible and can be implanted into the eye. The devices have a core comprising a drug and a polymeric outer layer which is substantially impermeable to the entrance of an environmental fluid and substantially impermeable to the release of the drug during a delivery period, and drug release is affected through an orifice in the outer layer. These devices have an orifice area of less than 10 % of the total surface area of the device and can be used to deliver a variety of drugs with varying degrees of solubility and or molecular weight. Methods are also provided for using these drugs delivery devices.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/426,141 US6331313B1 (en) | 1999-10-22 | 1999-10-22 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
| US09/426,141 | 1999-10-22 | ||
| CA002355313A CA2355313C (en) | 1999-10-22 | 2000-10-19 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002355313A Division CA2355313C (en) | 1999-10-22 | 2000-10-19 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CA2544460A1 true CA2544460A1 (en) | 2001-05-03 |
| CA2544460C CA2544460C (en) | 2009-04-07 |
Family
ID=36702811
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA002544460A Expired - Lifetime CA2544460C (en) | 1999-10-22 | 2000-10-19 | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Country Status (1)
| Country | Link |
|---|---|
| CA (1) | CA2544460C (en) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011079232A1 (en) * | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
| US8252307B2 (en) | 1999-03-22 | 2012-08-28 | Psivida Us, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| US8574659B2 (en) | 2000-04-26 | 2013-11-05 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
-
2000
- 2000-10-19 CA CA002544460A patent/CA2544460C/en not_active Expired - Lifetime
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8252307B2 (en) | 1999-03-22 | 2012-08-28 | Psivida Us, Inc. | Method for treating and/or preventing retinal diseases with sustained release corticosteroids |
| US8574659B2 (en) | 2000-04-26 | 2013-11-05 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US8574613B2 (en) | 2000-04-26 | 2013-11-05 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US9192579B2 (en) | 2000-04-26 | 2015-11-24 | Psivida Us, Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US9849085B2 (en) | 2000-04-26 | 2017-12-26 | Psivida Us Inc. | Sustained release drug delivery devices, methods of use, and methods of manufacturing thereof |
| US8871241B2 (en) | 2002-05-07 | 2014-10-28 | Psivida Us, Inc. | Injectable sustained release delivery devices |
| WO2011079232A1 (en) * | 2009-12-23 | 2011-06-30 | Psivida Us, Inc. | Sustained release delivery devices |
Also Published As
| Publication number | Publication date |
|---|---|
| CA2544460C (en) | 2009-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2355313A1 (en) | Controlled-release biocompatible ocular drug delivery implant devices and methods | |
| US4898733A (en) | Layered, compression molded device for the sustained release of a beneficial agent | |
| WO2005013936A3 (en) | Manufacture of long term drug delivery devices with polyurethane based polymers | |
| CA2230947A1 (en) | Implantable controlled release device to deliver drugs directly to an internal portion of the body | |
| WO2004010975A3 (en) | Controlled drug delivery | |
| CA2395077A1 (en) | Liquid composition of biodegradable block copolymer for drug delivery system and process for the preparation thereof | |
| CA2375714A1 (en) | Delayed total release two pulse gastrointestinal drug delivery system | |
| CA2305762A1 (en) | Delayed total release gastrointestinal drug delivery system | |
| WO2001008717A9 (en) | Controlled release implantable devices | |
| CN102014817A (en) | Ophthalmic devices for the controlled release of active agents | |
| WO2002047731A3 (en) | Drug delivery compositions and coated medical devices | |
| ATE319421T1 (en) | LOCAL MEDICINAL DELIVERY | |
| ATE554806T1 (en) | DEVICE FOR DELIVERING THERAPEUTIC AGENTS HAVING A SEPARATING PROTECTIVE LAYER | |
| WO2005115493A3 (en) | Thermal treatment of an implantable medical device | |
| MY133883A (en) | Gastrointestinal drug delivery system | |
| CA2187353A1 (en) | Liquid delivery compositions | |
| WO2004000379A8 (en) | Stent coatings with sustained drug release rate | |
| GEP20043334B (en) | Hydrogel-Driven Drug Dosage Form | |
| WO2004028570A3 (en) | A method for treating severe tinnitus | |
| CA2513751A1 (en) | Sustained release device and method for ocular delivery of adrenergic agents | |
| AU2001291526A1 (en) | Sustained release composition containing clarithromycin | |
| WO1998029095A3 (en) | Sustained release cisapride mini-tablet formulation | |
| CA2340898A1 (en) | Compositions and methods for treating intracellular infections | |
| WO2003008005A3 (en) | Catheter and implants for the delivery of therapeutic agents to tissues | |
| CA2544460A1 (en) | Controlled-release biocompatible ocular drug delivery implant devices and methods |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request | ||
| MKEX | Expiry |
Effective date: 20201019 |